These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26733325)

  • 1. Kinetics of human myeloid-derived suppressor cells after blood draw.
    Grützner E; Stirner R; Arenz L; Athanasoulia AP; Schrödl K; Berking C; Bogner JR; Draenert R
    J Transl Med; 2016 Jan; 14():2. PubMed ID: 26733325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid-derived suppressor cells in human peripheral blood: Optimized quantification in healthy donors and patients with metastatic renal cell carcinoma.
    Flörcken A; Takvorian A; Singh A; Gerhardt A; Ostendorf BN; Dörken B; Pezzutto A; Westermann J
    Immunol Lett; 2015 Dec; 168(2):260-7. PubMed ID: 26462434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR8 ligation induces apoptosis of monocytic myeloid-derived suppressor cells.
    Dang Y; Rutnam ZJ; Dietsch G; Lu H; Yang Y; Hershberg R; Disis ML
    J Leukoc Biol; 2018 Jan; 103(1):157-164. PubMed ID: 29345064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase-1 mRNA expression correlates with myeloid-derived suppressor cell levels in peripheral blood of NSCLC patients.
    Heuvers ME; Muskens F; Bezemer K; Lambers M; Dingemans AC; Groen HJM; Smit EF; Hoogsteden HC; Hegmans JPJJ; Aerts JGJV
    Lung Cancer; 2013 Sep; 81(3):468-474. PubMed ID: 23850196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer.
    Trellakis S; Bruderek K; Hütte J; Elian M; Hoffmann TK; Lang S; Brandau S
    Innate Immun; 2013 Jun; 19(3):328-36. PubMed ID: 23160385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells.
    Vollbrecht T; Stirner R; Tufman A; Roider J; Huber RM; Bogner JR; Lechner A; Bourquin C; Draenert R
    AIDS; 2012 Jul; 26(12):F31-7. PubMed ID: 22526518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Petersen-Baltussen HM; ter Laan M; Wesseling P; Adema GJ
    J Neuropathol Exp Neurol; 2015 May; 74(5):390-400. PubMed ID: 25853692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients.
    Gey A; Tadie JM; Caumont-Prim A; Hauw-Berlemont C; Cynober L; Fagon JY; Terme M; Diehl JL; Delclaux C; Tartour E
    Clin Exp Immunol; 2015 May; 180(2):280-8. PubMed ID: 25476957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood transportation on human peripheral mononuclear cell yield, phenotype and function: implications for immune cell biobanking.
    Posevitz-Fejfár A; Posevitz V; Gross CC; Bhatia U; Kurth F; Schütte V; Bar-Or A; Meuth SG; Wiendl H
    PLoS One; 2014; 9(12):e115920. PubMed ID: 25541968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer.
    Idorn M; Køllgaard T; Kongsted P; Sengeløv L; Thor Straten P
    Cancer Immunol Immunother; 2014 Nov; 63(11):1177-87. PubMed ID: 25085000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies.
    Duffy A; Zhao F; Haile L; Gamrekelashvili J; Fioravanti S; Ma C; Kapanadze T; Compton K; Figg WD; Greten TF
    Cancer Immunol Immunother; 2013 Feb; 62(2):299-307. PubMed ID: 23011590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: A prospective study.
    Hock BD; McKenzie JL; Cross NB; Currie MJ
    Transpl Immunol; 2015 Jun; 32(3):164-71. PubMed ID: 25968653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myeloid-derived suppressor cells in patients with breast cancer].
    Gonda K; Shibata M; Ohtake T; Yasuda M; Abe N; Watanabe K; Ando J; Okano M; Onozawa H; Tachibana K; Ohto H; Takenoshita S
    Gan To Kagaku Ryoho; 2012 Sep; 39(9):1363-8. PubMed ID: 22996770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.
    Mandruzzato S; Brandau S; Britten CM; Bronte V; Damuzzo V; Gouttefangeas C; Maurer D; Ottensmeier C; van der Burg SH; Welters MJ; Walter S
    Cancer Immunol Immunother; 2016 Feb; 65(2):161-9. PubMed ID: 26728481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proportion and function of peripheral myeloid-derived suppressor cells do not correlate with systemic inflammation in chronic obstructive pulmonary disease.
    Tan DB; Fernandez S; Price P; Moodley YP
    Hum Immunol; 2014 Jan; 75(1):5-9. PubMed ID: 24090682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry.
    Sacchi A; Tumino N; Grassi G; Casetti R; Cimini E; Bordoni V; Ammassari A; Antinori A; Agrati C
    PLoS One; 2018; 13(8):e0202920. PubMed ID: 30161175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophosphamide-induced myeloid-derived suppressor cell population is immunosuppressive but not identical to myeloid-derived suppressor cells induced by growing TC-1 tumors.
    Mikyšková R; Indrová M; Polláková V; Bieblová J; Símová J; Reiniš M
    J Immunother; 2012 Jun; 35(5):374-84. PubMed ID: 22576342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade.
    Ouzounova M; Lee E; Piranlioglu R; El Andaloussi A; Kolhe R; Demirci MF; Marasco D; Asm I; Chadli A; Hassan KA; Thangaraju M; Zhou G; Arbab AS; Cowell JK; Korkaya H
    Nat Commun; 2017 Apr; 8():14979. PubMed ID: 28382931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.
    Mandruzzato S; Solito S; Falisi E; Francescato S; Chiarion-Sileni V; Mocellin S; Zanon A; Rossi CR; Nitti D; Bronte V; Zanovello P
    J Immunol; 2009 May; 182(10):6562-8. PubMed ID: 19414811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.
    Hock BD; Mackenzie KA; Cross NB; Taylor KG; Currie MJ; Robinson BA; Simcock JW; McKenzie JL
    Nephrol Dial Transplant; 2012 Jan; 27(1):402-10. PubMed ID: 21617199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.